BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Oh, Where Vaccines Could Take Us

  2021 could very well have been “the year of the vaccine.” While this modality is certainly not new, the COVID-19 pandemic is sparking excitement about just what else they might be able to do.

  January 11, 2022

   · 

  6 min read

   · 

  Heather McKenzie
• 

  BioMidwest

  For mRNA Vaccines, Protection is Down to the T Follicular Helper Cells

  T follicular helper immune cells help antibody-producing cells create increasingly robust antibodies and also enhance the formation of certain types of immune memory.

  January 11, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  Gameto Nets $20M on Path to Redefining Reproductive Longevity

  Gameto has created a three-part platform for ovarian therapeutics that will address menopause and assisted fertility.

  January 11, 2022

   · 

  2 min read

   · 

  Kaylei Whalen
• 

  Business

  Amgen and Arrakis Aim to Destroy Disease with Targeted RNA Degraders

  Amgen will partner with Arrakis Therapeutics for an innovative collaboration to research and develop RNA degrader therapeutics.

  January 11, 2022

   · 

  2 min read

   · 

  Alvin Clavines
• 

  Drug Development

  Inconsistent Results Cause Halt to CLN6 Batten Disease Program

  Amicus announced that it is halting its CLN6 Batten disease gene therapy program after studies failed to achieve consistent results.

  January 11, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Biotech Bay

  Roche Makes $290M Investment in Freenome’s Colorectal Cancer Screening Program

  Roche’s investment is aimed at supporting the development of Freenome’s colorectal cancer detection technology.

  January 11, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  JPM Kicked Off with Fresh News from Pfizer, BMS, Illumina and Novavax

  The 2022 virtual J.P. Morgan Healthcare Conference got off to a roaring start Monday with deal announcements and plans to drive biopharma companies through the coming year.

  January 11, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  British Firm Identifies Seven Late-Stage Drugs with Blockbuster Potential

  U.K.-based Clarivate Plc has identified seven late-stage assets or recently-approved drugs that could hit the billion-dollar per year mark within five years.

  January 11, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Know Your Masks: Protection in the Time of Omicron

  The Centers for Disease Control recommends wearing a mask in health care settings and other places where people around may have risk factors for severe consequences of COVID-19.

  January 11, 2022

   · 

  5 min read

   · 

  Sreetama Dutt
• 

  Business

  Xenotransplant Advocates Rejoice as a Pig’s Heart Beats in Man’s Chest

  Gene editing has broken through to a new level as a Maryland man recovers from surgery in which a heart from a genetically modified pig may save his life.

  January 11, 2022

   · 

  3 min read

   · 

  Kate Goodwin